Response by Kazi et al to Letter Regarding Article, "Cost-Effectiveness of Tafamidis Therapy for Transthyretin Amyloid Cardiomyopathy".
Circulation
; 142(15): e212-e213, 2020 10 13.
Article
in En
| MEDLINE
| ID: mdl-33044859
Full text:
1
Database:
MEDLINE
Main subject:
Amyloid Neuropathies, Familial
/
Cardiomyopathies
Type of study:
Health_economic_evaluation
Limits:
Humans
Language:
En
Journal:
Circulation
Year:
2020
Type:
Article